• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB

MESOBLAST LIMITED - Announcements

1.08% ! $2.29
Market Cap $2.931B  !

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE18/07/25 download Created with Sketch. 455.43KB
MSB FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive ApprovalPRICE SENSITIVE15/05/25 download Created with Sketch. 173.92KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/25 download Created with Sketch. 440.59KB
MSB Mesoblast Cell Therapy Products Not Subject to U.S. TariffsPRICE SENSITIVE04/04/25 download Created with Sketch. 185.24KB
MSB First Children To Begin Treatment, Medicaid Covers RyoncilPRICE SENSITIVE31/03/25 download Created with Sketch. 186.79KB
MSB Ryoncil Is Now Available For Purchase In The United StatesPRICE SENSITIVE27/03/25 download Created with Sketch. 188.31KB
MSB ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200PRICE SENSITIVE28/02/25 download Created with Sketch. 137.56KB
MSB Ryoncil Pricing Set and Available This QuarterPRICE SENSITIVE27/02/25 download Created with Sketch. 395.42KB
MSB Corporate Presentation and Half Year Financial ResultsPRICE SENSITIVE27/02/25 download Created with Sketch. 2.07MB
MSB Half Year Report and Accounts (including Appendix 4D)PRICE SENSITIVE27/02/25 download Created with Sketch. 1.77MB
MSB Ryoncil Commercial Launch Update and Product PipelinePRICE SENSITIVE31/01/25 download Created with Sketch. 245.71KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/25 download Created with Sketch. 427.9KB
MSB MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCHPRICE SENSITIVE14/01/25 download Created with Sketch. 225.74KB
MSB Trading HaltPRICE SENSITIVE10/01/25 download Created with Sketch. 217.26KB
MSB Pause in TradingPRICE SENSITIVE10/01/25 download Created with Sketch. 114.73KB
MSB FDA Approves Mesoblast RyoncilPRICE SENSITIVE19/12/24 download Created with Sketch. 218.24KB
MSB Material AnnouncementPRICE SENSITIVE05/12/24 download Created with Sketch. 112.64KB
MSB Pause in TradePRICE SENSITIVE05/12/24 download Created with Sketch. 115.3KB
MSB FDA Grants Mesoblast RMAT DesignationPRICE SENSITIVE05/12/24 download Created with Sketch. 196.86KB
MSB Response to ASX Price QueryPRICE SENSITIVE14/11/24 download Created with Sketch. 364.45KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/24 download Created with Sketch. 441.54KB
MSB Mesoblast Option to Issue up to US$50m Convertible NotesPRICE SENSITIVE30/09/24 download Created with Sketch. 193.91KB
MSB MSB Annual Financial Results and Operational UpdatePRICE SENSITIVE29/08/24 download Created with Sketch. 548.01KB
MSB Annual Financial Results PresentationPRICE SENSITIVE29/08/24 download Created with Sketch. 2.38MB
MSB Preliminary Final Report including Appendix 4EPRICE SENSITIVE29/08/24 download Created with Sketch. 2.53MB
MSB Class Action ResolutionPRICE SENSITIVE21/08/24 download Created with Sketch. 128.66KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/24 download Created with Sketch. 432.15KB
MSB FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-LPRICE SENSITIVE23/07/24 download Created with Sketch. 185.89KB
MSB Mesoblast Resubmits BLA with FDA for Ryoncil ApprovalPRICE SENSITIVE09/07/24 download Created with Sketch. 178.36KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 416.56KB
MSB FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLAPRICE SENSITIVE26/03/24 download Created with Sketch. 159.39KB
MSB Pause in TradingPRICE SENSITIVE26/03/24 download Created with Sketch. 114KB
MSB Mesoblast Completes Placement and Entitlement OfferPRICE SENSITIVE14/03/24 download Created with Sketch. 159.66KB
MSB FDA Supports Accelerated Approval Pathway for Heart FailurePRICE SENSITIVE11/03/24 download Created with Sketch. 183.32KB
MSB MSB Q2 Financial Results and Operational HighlightsPRICE SENSITIVE29/02/24 download Created with Sketch. 486.32KB
MSB Half Year Financial Results PresentationPRICE SENSITIVE29/02/24 download Created with Sketch. 1.7MB
MSB Half Year Report and Accounts (including Appendix 4D)PRICE SENSITIVE29/02/24 download Created with Sketch. 1.66MB
MSB FDA Grants Orphan Drug Designation for RevascorPRICE SENSITIVE15/02/24 download Created with Sketch. 176.6KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 423.11KB
MSB FDA Grants Rare Pediatric Disease Designation for RevascorPRICE SENSITIVE19/01/24 download Created with Sketch. 181.5KB
MSB Information For Retail ShareholdersPRICE SENSITIVE08/12/23 download Created with Sketch. 2.54MB
MSB Mesoblast Completes Institutional AllocationPRICE SENSITIVE05/12/23 download Created with Sketch. 197.91KB
MSB Entitlement Offer and Placement Investor PresentationPRICE SENSITIVE04/12/23 download Created with Sketch. 2.06MB
MSB MSB Launches Entitlement Offer and PlacementPRICE SENSITIVE04/12/23 download Created with Sketch. 292.56KB
MSB Trading HaltPRICE SENSITIVE01/12/23 download Created with Sketch. 217.16KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 398.85KB
MSB MSB Annual Financial Results and Operational UpdatePRICE SENSITIVE31/08/23 download Created with Sketch. 430.53KB
MSB Preliminary Final Report including Appendix 4EPRICE SENSITIVE31/08/23 download Created with Sketch. 2.9MB
MSB Update on BLA for Graft Versus Host DiseasePRICE SENSITIVE04/08/23 download Created with Sketch. 178.56KB
MSB Trading HaltPRICE SENSITIVE02/08/23 download Created with Sketch. 195.14KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 401.67KB
MSB MSB Reports Q3 Financial Results and Operational HighlightsPRICE SENSITIVE26/05/23 download Created with Sketch. 402.9KB
MSB Third Quarter Financial Results on Form 6-KPRICE SENSITIVE26/05/23 download Created with Sketch. 591.58KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 416.6KB
MSB Reinstatement to Official QuotationPRICE SENSITIVE26/04/23 download Created with Sketch. 86.01KB
MSB Mesoblast Completes Private PlacementPRICE SENSITIVE26/04/23 download Created with Sketch. 169.21KB
MSB Voluntary SuspensionPRICE SENSITIVE24/04/23 download Created with Sketch. 281.47KB
MSB Trading HaltPRICE SENSITIVE20/04/23 download Created with Sketch. 281.84KB
MSB Pause in TradingPRICE SENSITIVE20/04/23 download Created with Sketch. 115.82KB
MSB FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-LPRICE SENSITIVE08/03/23 download Created with Sketch. 195.02KB
MSB Pause in TradingPRICE SENSITIVE08/03/23 download Created with Sketch. 114.29KB
MSB DREAM HF Trial Published in JACCPRICE SENSITIVE28/02/23 download Created with Sketch. 226.95KB
MSB MSB Q2 Financial Results and Operational HighlightsPRICE SENSITIVE28/02/23 download Created with Sketch. 408.95KB
MSB Half Yearly Report and AccountsPRICE SENSITIVE28/02/23 download Created with Sketch. 1.67MB
MSB Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHDPRICE SENSITIVE01/02/23 download Created with Sketch. 195.59KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 419.11KB
MSB Extension of Undrawn US$30 million FacilityPRICE SENSITIVE23/12/22 download Created with Sketch. 161.36KB
MSB Long-Term Survival for Acute GvHD Treatment with RemestemcelPRICE SENSITIVE23/11/22 download Created with Sketch. 189.85KB
MSB MSB Q1 Financial Results and Operational HighlightsPRICE SENSITIVE23/11/22 download Created with Sketch. 439.61KB
MSB First Quarter Financial Results on Form 6-KPRICE SENSITIVE23/11/22 download Created with Sketch. 500.21KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 419.32KB
MSB Submits New Information to FDA IND File for SR-aGVHDPRICE SENSITIVE03/10/22 download Created with Sketch. 168.87KB
MSB MSB Annual Financial Results and Operational HighlightsPRICE SENSITIVE31/08/22 download Created with Sketch. 386.1KB
MSB Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 3.16MB
MSB US$45 Million Private Placement to Major ShareholdersPRICE SENSITIVE09/08/22 download Created with Sketch. 157.61KB
MSB Reinstatement to QuotationPRICE SENSITIVE09/08/22 download Created with Sketch. 85.62KB
MSB Voluntary SuspensionPRICE SENSITIVE08/08/22 download Created with Sketch. 221.75KB
MSB Trading HaltPRICE SENSITIVE04/08/22 download Created with Sketch. 206.88KB
MSB Pause in TradingPRICE SENSITIVE04/08/22 download Created with Sketch. 116.13KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 444.42KB
MSB Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACEPRICE SENSITIVE19/07/22 download Created with Sketch. 185.89KB
MSB Third Quarter Results PresentationPRICE SENSITIVE01/06/22 download Created with Sketch. 2.69MB
MSB MSB Q3 Financial Results and Operational HighlightsPRICE SENSITIVE01/06/22 download Created with Sketch. 402.97KB
MSB Third Quarter Financial Results on Form 6-KPRICE SENSITIVE01/06/22 download Created with Sketch. 577.99KB
MSB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 443.8KB
MSB S&P DJI Announces March 2022 Quarterly RebalancePRICE SENSITIVE04/03/22 download Created with Sketch. 175.5KB
MSB MSB Q2 Financial Results and Operational HighlightsPRICE SENSITIVE25/02/22 download Created with Sketch. 654.15KB
MSB Second Quarter Results PresentationPRICE SENSITIVE25/02/22 download Created with Sketch. 2.82MB
MSB Half Yearly Report and AccountsPRICE SENSITIVE25/02/22 download Created with Sketch. 948.77KB
MSB Ulcerative Colitis & Crohns Results Presented at ECCOPRICE SENSITIVE21/02/22 download Created with Sketch. 192.81KB
MSB Appendix 4C Quarterly Activity ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 340.86KB
MSB FDAs OTAT Agrees to Primary Endpoint for Back PainPRICE SENSITIVE16/12/21 download Created with Sketch. 171.73KB
MSB Update on Novartis AgreementPRICE SENSITIVE14/12/21 download Created with Sketch. 129.26KB
MSB Pause in TradingPRICE SENSITIVE14/12/21 download Created with Sketch. 116.22KB
MSB MSB Q1 Financial Results and Operational HighlightsPRICE SENSITIVE24/11/21 download Created with Sketch. 563.41KB
MSB First Quarter Financial Results on Form 6-KPRICE SENSITIVE24/11/21 download Created with Sketch. 518.14KB
MSB MSB and Oaktree Conclude Refinancing of Senior Debt FacilityPRICE SENSITIVE22/11/21 download Created with Sketch. 133.88KB
MSB AHA Late-Breaker - Rexlemestrocel Improves Cardiac OutcomesPRICE SENSITIVE15/11/21 download Created with Sketch. 205.61KB
MSB Appendix 4C Quarterly Activity ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 345.66KB
MSB MSB Annual Financial Results and Operational ProgressPRICE SENSITIVE31/08/21 download Created with Sketch. 632.34KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
18/07/25PRICE SENSITIVE download Created with Sketch. 455.43KB
MSB FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15/05/25PRICE SENSITIVE download Created with Sketch. 173.92KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25PRICE SENSITIVE download Created with Sketch. 440.59KB
MSB Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
04/04/25PRICE SENSITIVE download Created with Sketch. 185.24KB
MSB First Children To Begin Treatment, Medicaid Covers Ryoncil
31/03/25PRICE SENSITIVE download Created with Sketch. 186.79KB
MSB Ryoncil Is Now Available For Purchase In The United States
27/03/25PRICE SENSITIVE download Created with Sketch. 188.31KB
MSB ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200
28/02/25PRICE SENSITIVE download Created with Sketch. 137.56KB
MSB Ryoncil Pricing Set and Available This Quarter
27/02/25PRICE SENSITIVE download Created with Sketch. 395.42KB
MSB Corporate Presentation and Half Year Financial Results
27/02/25PRICE SENSITIVE download Created with Sketch. 2.07MB
MSB Half Year Report and Accounts (including Appendix 4D)
27/02/25PRICE SENSITIVE download Created with Sketch. 1.77MB
MSB Ryoncil Commercial Launch Update and Product Pipeline
31/01/25PRICE SENSITIVE download Created with Sketch. 245.71KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25PRICE SENSITIVE download Created with Sketch. 427.9KB
MSB MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
14/01/25PRICE SENSITIVE download Created with Sketch. 225.74KB
MSB Trading Halt
10/01/25PRICE SENSITIVE download Created with Sketch. 217.26KB
MSB Pause in Trading
10/01/25PRICE SENSITIVE download Created with Sketch. 114.73KB
MSB FDA Approves Mesoblast Ryoncil
19/12/24PRICE SENSITIVE download Created with Sketch. 218.24KB
MSB Material Announcement
05/12/24PRICE SENSITIVE download Created with Sketch. 112.64KB
MSB Pause in Trade
05/12/24PRICE SENSITIVE download Created with Sketch. 115.3KB
MSB FDA Grants Mesoblast RMAT Designation
05/12/24PRICE SENSITIVE download Created with Sketch. 196.86KB
MSB Response to ASX Price Query
14/11/24PRICE SENSITIVE download Created with Sketch. 364.45KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24PRICE SENSITIVE download Created with Sketch. 441.54KB
MSB Mesoblast Option to Issue up to US$50m Convertible Notes
30/09/24PRICE SENSITIVE download Created with Sketch. 193.91KB
MSB MSB Annual Financial Results and Operational Update
29/08/24PRICE SENSITIVE download Created with Sketch. 548.01KB
MSB Annual Financial Results Presentation
29/08/24PRICE SENSITIVE download Created with Sketch. 2.38MB
MSB Preliminary Final Report including Appendix 4E
29/08/24PRICE SENSITIVE download Created with Sketch. 2.53MB
MSB Class Action Resolution
21/08/24PRICE SENSITIVE download Created with Sketch. 128.66KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24PRICE SENSITIVE download Created with Sketch. 432.15KB
MSB FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
23/07/24PRICE SENSITIVE download Created with Sketch. 185.89KB
MSB Mesoblast Resubmits BLA with FDA for Ryoncil Approval
09/07/24PRICE SENSITIVE download Created with Sketch. 178.36KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 416.56KB
MSB FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
26/03/24PRICE SENSITIVE download Created with Sketch. 159.39KB
MSB Pause in Trading
26/03/24PRICE SENSITIVE download Created with Sketch. 114KB
MSB Mesoblast Completes Placement and Entitlement Offer
14/03/24PRICE SENSITIVE download Created with Sketch. 159.66KB
MSB FDA Supports Accelerated Approval Pathway for Heart Failure
11/03/24PRICE SENSITIVE download Created with Sketch. 183.32KB
MSB MSB Q2 Financial Results and Operational Highlights
29/02/24PRICE SENSITIVE download Created with Sketch. 486.32KB
MSB Half Year Financial Results Presentation
29/02/24PRICE SENSITIVE download Created with Sketch. 1.7MB
MSB Half Year Report and Accounts (including Appendix 4D)
29/02/24PRICE SENSITIVE download Created with Sketch. 1.66MB
MSB FDA Grants Orphan Drug Designation for Revascor
15/02/24PRICE SENSITIVE download Created with Sketch. 176.6KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 423.11KB
MSB FDA Grants Rare Pediatric Disease Designation for Revascor
19/01/24PRICE SENSITIVE download Created with Sketch. 181.5KB
MSB Information For Retail Shareholders
08/12/23PRICE SENSITIVE download Created with Sketch. 2.54MB
MSB Mesoblast Completes Institutional Allocation
05/12/23PRICE SENSITIVE download Created with Sketch. 197.91KB
MSB Entitlement Offer and Placement Investor Presentation
04/12/23PRICE SENSITIVE download Created with Sketch. 2.06MB
MSB MSB Launches Entitlement Offer and Placement
04/12/23PRICE SENSITIVE download Created with Sketch. 292.56KB
MSB Trading Halt
01/12/23PRICE SENSITIVE download Created with Sketch. 217.16KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 398.85KB
MSB MSB Annual Financial Results and Operational Update
31/08/23PRICE SENSITIVE download Created with Sketch. 430.53KB
MSB Preliminary Final Report including Appendix 4E
31/08/23PRICE SENSITIVE download Created with Sketch. 2.9MB
MSB Update on BLA for Graft Versus Host Disease
04/08/23PRICE SENSITIVE download Created with Sketch. 178.56KB
MSB Trading Halt
02/08/23PRICE SENSITIVE download Created with Sketch. 195.14KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 401.67KB
MSB MSB Reports Q3 Financial Results and Operational Highlights
26/05/23PRICE SENSITIVE download Created with Sketch. 402.9KB
MSB Third Quarter Financial Results on Form 6-K
26/05/23PRICE SENSITIVE download Created with Sketch. 591.58KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 416.6KB
MSB Reinstatement to Official Quotation
26/04/23PRICE SENSITIVE download Created with Sketch. 86.01KB
MSB Mesoblast Completes Private Placement
26/04/23PRICE SENSITIVE download Created with Sketch. 169.21KB
MSB Voluntary Suspension
24/04/23PRICE SENSITIVE download Created with Sketch. 281.47KB
MSB Trading Halt
20/04/23PRICE SENSITIVE download Created with Sketch. 281.84KB
MSB Pause in Trading
20/04/23PRICE SENSITIVE download Created with Sketch. 115.82KB
MSB FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
08/03/23PRICE SENSITIVE download Created with Sketch. 195.02KB
MSB Pause in Trading
08/03/23PRICE SENSITIVE download Created with Sketch. 114.29KB
MSB DREAM HF Trial Published in JACC
28/02/23PRICE SENSITIVE download Created with Sketch. 226.95KB
MSB MSB Q2 Financial Results and Operational Highlights
28/02/23PRICE SENSITIVE download Created with Sketch. 408.95KB
MSB Half Yearly Report and Accounts
28/02/23PRICE SENSITIVE download Created with Sketch. 1.67MB
MSB Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
01/02/23PRICE SENSITIVE download Created with Sketch. 195.59KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 419.11KB
MSB Extension of Undrawn US$30 million Facility
23/12/22PRICE SENSITIVE download Created with Sketch. 161.36KB
MSB Long-Term Survival for Acute GvHD Treatment with Remestemcel
23/11/22PRICE SENSITIVE download Created with Sketch. 189.85KB
MSB MSB Q1 Financial Results and Operational Highlights
23/11/22PRICE SENSITIVE download Created with Sketch. 439.61KB
MSB First Quarter Financial Results on Form 6-K
23/11/22PRICE SENSITIVE download Created with Sketch. 500.21KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 419.32KB
MSB Submits New Information to FDA IND File for SR-aGVHD
03/10/22PRICE SENSITIVE download Created with Sketch. 168.87KB
MSB MSB Annual Financial Results and Operational Highlights
31/08/22PRICE SENSITIVE download Created with Sketch. 386.1KB
MSB Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 3.16MB
MSB US$45 Million Private Placement to Major Shareholders
09/08/22PRICE SENSITIVE download Created with Sketch. 157.61KB
MSB Reinstatement to Quotation
09/08/22PRICE SENSITIVE download Created with Sketch. 85.62KB
MSB Voluntary Suspension
08/08/22PRICE SENSITIVE download Created with Sketch. 221.75KB
MSB Trading Halt
04/08/22PRICE SENSITIVE download Created with Sketch. 206.88KB
MSB Pause in Trading
04/08/22PRICE SENSITIVE download Created with Sketch. 116.13KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 444.42KB
MSB Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
19/07/22PRICE SENSITIVE download Created with Sketch. 185.89KB
MSB Third Quarter Results Presentation
01/06/22PRICE SENSITIVE download Created with Sketch. 2.69MB
MSB MSB Q3 Financial Results and Operational Highlights
01/06/22PRICE SENSITIVE download Created with Sketch. 402.97KB
MSB Third Quarter Financial Results on Form 6-K
01/06/22PRICE SENSITIVE download Created with Sketch. 577.99KB
MSB Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22PRICE SENSITIVE download Created with Sketch. 443.8KB
MSB S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22PRICE SENSITIVE download Created with Sketch. 175.5KB
MSB MSB Q2 Financial Results and Operational Highlights
25/02/22PRICE SENSITIVE download Created with Sketch. 654.15KB
MSB Second Quarter Results Presentation
25/02/22PRICE SENSITIVE download Created with Sketch. 2.82MB
MSB Half Yearly Report and Accounts
25/02/22PRICE SENSITIVE download Created with Sketch. 948.77KB
MSB Ulcerative Colitis & Crohns Results Presented at ECCO
21/02/22PRICE SENSITIVE download Created with Sketch. 192.81KB
MSB Appendix 4C Quarterly Activity Report
31/01/22PRICE SENSITIVE download Created with Sketch. 340.86KB
MSB FDAs OTAT Agrees to Primary Endpoint for Back Pain
16/12/21PRICE SENSITIVE download Created with Sketch. 171.73KB
MSB Update on Novartis Agreement
14/12/21PRICE SENSITIVE download Created with Sketch. 129.26KB
MSB Pause in Trading
14/12/21PRICE SENSITIVE download Created with Sketch. 116.22KB
MSB MSB Q1 Financial Results and Operational Highlights
24/11/21PRICE SENSITIVE download Created with Sketch. 563.41KB
MSB First Quarter Financial Results on Form 6-K
24/11/21PRICE SENSITIVE download Created with Sketch. 518.14KB
MSB MSB and Oaktree Conclude Refinancing of Senior Debt Facility
22/11/21PRICE SENSITIVE download Created with Sketch. 133.88KB
MSB AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
15/11/21PRICE SENSITIVE download Created with Sketch. 205.61KB
MSB Appendix 4C Quarterly Activity Report
29/10/21PRICE SENSITIVE download Created with Sketch. 345.66KB
MSB MSB Annual Financial Results and Operational Progress
31/08/21PRICE SENSITIVE download Created with Sketch. 632.34KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.29
Change
-0.025(1.08%)
Mkt cap ! $2.931B
Open High Low Value Volume
$2.31 $2.34 $2.26 $4.117M 1.806M

Buyers (Bids)

No. Vol. Price($)
23 28384 $2.28
 

Sellers (Offers)

Price($) Vol. No.
$2.29 88162 30
View Market Depth
Last trade - 14.21pm 11/08/2025 (20 minute delay) ?
Last
$2.29
  Change
-0.025 ( 1.62 %)
Open High Low Volume
$2.32 $2.33 $2.26 610328
Last updated 14.39pm 11/08/2025 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.